Results 1 to 10 of about 2,698,478 (214)
Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid) [PDF]
Mesalamine, known as 5-aminosalicylic acid, is a medication used primarily in the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.
Robert D. Crapnell +2 more
doaj +3 more sources
Prospective Questionnaire Survey on Adherence to Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis [PDF]
Background Adherence to 5‐aminosalicylic acid (5‐ASA), an anchor drug for ulcerative colitis (UC), affects remission maintenance. This study aimed to investigate the current status of adherence to 5‐ASA and identify the factors associated with adherence.
Tsuyoshi Beppu +9 more
doaj +2 more sources
Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid [PDF]
5-Aminosalicylic acid (5-ASA) is recommended for managing ulcerative colitis. Common adverse effects associated with 5-ASA include gastrointestinal disorders, headaches, and skin rashes.
Hye Young Lee, Dong Hoon Baek
doaj +2 more sources
Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid. [PDF]
The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated.
Diana Serra +4 more
doaj +1 more source
This work includes a new spectrophotometric method for the determination para aminosalicylic acid in aqueous medium based on the oxidation by NaIO4 and coupling with 4-Amino Antipyrine producing a red dye soluble in water and of גmax of 516 nm.
Asma'a H. Shakir
doaj +1 more source
In this work, we determined the influenced of the reaction time at the synthesis of gold nanoparticles (AuNPs) by p-aminosalicylic acid and p-aminobenzoic acid as reducing agent.
Abdul Aji +2 more
doaj +1 more source
Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension
Background The gut and gut microbiota, which were previously neglected in blood pressure regulation, are becoming increasingly recognized as factors contributing to hypertension. Diseases affecting the gut such as inflammatory bowel disease (IBD) present
Xue Mei +7 more
doaj +1 more source
Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug [PDF]
Objective(s): 4-aminosalicylic acid (4-ASA) is an isomer of mesalazine that has recently been shown to be effective against inflammatory bowel disease (IBD), and more specifically, ulcerative colitis. However, the majority of orally administered 4-ASA is
Fatemeh Sadeghi +5 more
doaj +1 more source
Resveratrol modulates cytokine-induced Jak/STAT activation more efficiently than 5-aminosalicylic acid: an in vitro approach. [PDF]
Many advances have been recently made focused on the valuable help of dietary polyphenols in chronic inflammatory diseases. On the other hand, current treatment options for intestinal bowel disease patients are unsatisfying and, for this reason, it is ...
Diana Serra +4 more
doaj +1 more source

